Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-08-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
114年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in consolidated equity for the first half of the year 2025 (民國114年上半年度) and the same period in the previous year. It includes comprehensive financial data such as share capital, capital surplus, legal reserves, retained earnings, and other equity components. The presence of actual financial figures and the focus on a half-year period indicate this is a substantive financial report for a period shorter than a full fiscal year. The document length is 4270 characters, which is sufficient to contain detailed financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-12 Chinese
114年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company, 中化控股. It includes specific financial figures, investment methods, and regulatory limits. The content is focused on investment details rather than a full financial report or earnings release. The document length is 1818 characters, which is relatively short and does not appear to be a full annual or interim report. It is not an announcement of a report publication but a regulatory disclosure of investment information. This type of document aligns best with Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-08-12 Chinese
114年第2季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief tabular disclosure of investment holdings and related financial figures for a specific quarter (114年2季, which corresponds to the second quarter of the 114th year in the Taiwanese calendar). It includes investment amounts, ownership percentages, and recognized investment gains or losses. The document length is only 741 characters, indicating it is a short disclosure rather than a full financial report. There is no indication that this is a full annual or interim report, audit report, or earnings release. The content aligns with a regulatory filing or a general disclosure of investment information rather than a detailed report. Given the short length and nature of the data, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-08-12 Chinese
功能性委員會成員
Regulatory Filings Classification · 95% confidence The document is a brief tabular disclosure from a public information observation station, listing company code, name, establishment date, audit committee members, financial/accounting expertise, independent directors, total directors, and operational information. It is very short (383 characters) and contains no financial statements, no management discussion, no voting results, no legal proceedings, no capital changes, or any other detailed report content. It appears to be a regulatory disclosure about board composition and audit committee members, but not a full governance report or management report. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-08-12 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 100% confidence The document is a short announcement (898 characters) about a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced, and no mention of financial results or management changes beyond the name change. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a corporate name change and does not fit into more specific categories like Annual Report, Management Information, or Capital Update.
2025-08-12 Chinese
114年7月營業收入
Regulatory Filings Classification · 95% confidence The document is very short (597 characters) and consists mainly of a summary table listing company codes and names, with a note about monthly revenue reporting by subsidiaries. There is no detailed financial data, no mention of a specific report type, no regulatory certification, or any announcement of voting results, management changes, or legal proceedings. The content appears to be a general regulatory disclosure or informational summary without substantive financial or corporate event details. Given the lack of specific report content or announcement, and the nature of the text as a general regulatory disclosure, the best fit is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2025-08-11 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.